Chronic myelogenous leukemia response to imatinib: Philadelphia chromosome positive CD34+ cells - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS3518

Chronic myelogenous leukemia response to imatinib: Philadelphia chromosome positive CD34+ cells

Analysis of Philadelphia chromosome-positive CD34+ cells of chronic myelogenous leukemia patients treated with imatinib. The anti-cancer drug imatinib is a selective bcr-abl tyrosine kinase inhibitor. Results provide insight into the molecular events affected by bcr-abl inhibition through imatinib.

Organism:: Homo sapiens

Type:: Expression profiling by array, count, 2 agent, 6 individual sets

Platform:: GPL571
Series:: GSE12211
12 Samples

Download data: CEL, CHP

DataSet

Accession:: GDS3518

ID:: 3518

PubMed Similar studies GEO Profiles Analyze DataSet

Supplemental Content

Related information

PubMed
Related PubMed entries
Similar studies
Similar studies
GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Related DataSets for GEO Profiles (Select 59467004) (1)
GEO DataSets
Chronic myelogenous leukemia response to imatinib: Philadelphia chromosome posit...
Chronic myelogenous leukemia response to imatinib: Philadelphia chromosome positive CD34+ cells
Accession: GDS3518

GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets